Pharma News
-
Otsuka, Lundbeck files NDA for schizophrenia drug
Pharma | News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2014
Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to...Read more
-
Sanofi, Bristol-Myers Squibb to restructuring alliance agreement
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Sanofi and Bristol-Myers Squibb Company have restructured their long-term alliance following the loss of excl...Read more
-
Taiho seeks Japanese nod for oral cancer agent
Pharma | News | By BioSpectrum Bureau | 0 Comment | 28 Feb, 2013
Singapore: Taiho Pharmaceutical submitted an application for approval of the manufacture and marketing of the novel oral...Read more
-
FDA approves Boehringer's lung cancer drug Gilotrif
Pharma | News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2013
Singapore: US FDA has approved Boehringer Ingelheim' Gilotrif (afatinib) tablets for oral use, as a new first-line (init...Read more
-
Big pharma to drive R&D innovation with $4.4 bn
Pharma | News | By BioSpectrum Bureau | 0 Comment | 11 Jul, 2013
Singapore: The European Commission (EC) and other leading pharma giants have come together to invest $4.4 billion into p...Read more
-
Cadila chairman Indravadan Modi passes away
Pharma | News | By BioSpectrum Bureau | 0 Comment | 27 Nov, 2012
Bangalore: Veteran industrialist and one of pioneers of Indian pharmaceuticals industry Mr Indravadan Modi, the chairman...Read more
-
NIH study: Diabetes drug Metformin extends life
Pharma | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013
Singapore: Long-term treatment with the type 2 diabetes drug metformin improves health and longevity of male mice when s...Read more
-
Bayer Russia to hire 800 staff, increase sales to $1.73 bn
Pharma | News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2013
Singapore: Bayer is going to expand its operations in Russia by adding more than 800 staff over the next four years to f...Read more
-
Multiple organzations join hands to curb fake drug business
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: US Pharmacopeial Convention (USP) is gearing up its efforts to combat fake medicine circulating in the market...Read more
-
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Eisai announced that its U.S. subsidiary has received approval from the U.S. Food and Drug Administration (F...Read more
-
First-of-its-kind osteoarthritis study done in India
Pharma | News | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2012
Bangalore: Signaling relief to over 15 million knee-osteoarthritis patients in India, the world's first study "Osteoart...Read more
-
Novartis liver cancer trial with Afinitor flops
Pharma | News | By BioSpectrum Bureau | 0 Comment | 09 Aug, 2013
Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not e...Read more
-
Oramed submits pre-IND for exenatide to FDA
Pharma | Regulatory | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2013
Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a pre-Investigational New Drug (...Read more
-
Alexion to acquire Synageva biopharma for $8.4 bn deal
Pharma | News | By BioSpectrum Bureau | 0 Comment | 07 May, 2015
Singapore: Alexion pharmaceuticals recently announced the acquisition of Synageva Biopharma for $8.4 billion. US-based S...Read more
-
Director resigns at China Nepstar Chain Drugstore
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Mr. Gary Siu Kwan Sik has resigned as an independent director of China Nepstar Chain Drugstore, the largest d...Read more
-
Pharma | News | By BioSpectrum Bureau | 0 Comment | 12 Nov, 2012
Singapore: DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in A...Read more
-
Innovative dual chamber syringe for pharma market
Pharma | News | By BioSpectrum Bureau | 0 Comment | 05 Jun, 2012
Singapore: Japan-based Arte and German company ProJect Pharmaceutics are working closely on the development of a new typ...Read more
-
Indian FIPB clears pharma FDI proposals worth $536 mn
Pharma | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2012
New Delhi: The Indian Foreign Investment Promotion Board (FIPB), which is the foreign investment approval authority, has...Read more
